Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

324

HTML

1781

Figures (1-1)

118

Tables (1-3)

129

Sum=2352

Aug 7, 2006 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 7, 2006; 12(29): 4716-4720
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4716

Figure 1 N/OFQ (pg/mL) and α-FP (ng/mL) values in patients with HCC, with cirrhosis and in healthy controls.

Citation: Spadaro A, Ajello A, Luigiano C, Morace C, Resta ML, Berlinghieri G, Campo S, Scisca C, Alibrandi A, D’arrigo G, Alessi N, Ferraù O, Freni MA. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2006; 12(29): 4716-4720
URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4716.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i29.4716